1 insider bought €62k of shares over the last 90 days, the latest by 강재구, filed 30 Sept 2026.
WooGene B&G Co., Ltd: what insiders have been doing
WooGene B&G Co., Ltd belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Over the twelve months to 22 October 2026, 19 filings were filed, from 4 insiders.
Both sides are active: 9 purchases and 4 sales, from 3 insiders and 3 insiders respectively. The totals do not cover 13 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 chief executives, 1 major shareholder and 1 senior executive.
With 19 filings in twelve months, the company is more active than the median of 7 filings across the 2,650 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 13 purchases and 4 sales.
The last purchase on record was published on 30 September 2026, which is 40 days ago. The median gap between a trade and its publication by DART (FSS) is 10 days. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at UCB also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +5.3%Entry ₩2,535 · Close 21 Oct 2026 ₩2,670
- +3.2%Entry ₩2,588 · Close 21 Oct 2026 ₩2,670
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 35,358 sharesShareKRXDART:20260930000533Canonical exit: 29 Dec 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 261,581 sharesKRXDART:20260715000324Canonical exit: 13 Oct 2026 (T+90)
- 146,436 sharesShareKRXDART:20260715000345Canonical exit: 13 Oct 2026 (T+90)
- 291,826 sharesKRXDART:20260706000210Canonical exit: 4 Oct 2026 (T+90)
- 652 sharesShareKRXDART:20260622000338Canonical exit: 20 Sept 2026 (T+90)
- 179,515 sharesShareKRXDART:20260622000316Canonical exit: 20 Sept 2026 (T+90)
- 115,090 sharesKRXDART:20260609000269Canonical exit: 7 Sept 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 16,124 sharesShareKRXDART:20260609000327Canonical exit: 7 Sept 2026 (T+90)
- 50,951 sharesShareKRXDART:20260609000293Canonical exit: 7 Sept 2026 (T+90)
- 5,376,214 sharesKRXDART:20260528000615
- 1,629,984 sharesShareKRXDART:20260511000550
- 13,040 sharesShareKRXDART:20260511000565
- 3,386,515 sharesShareKRXDART:20260511000533
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 47 declarations
About WooGene B&G Co., Ltd
우진비앤지 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.
